Four-Group Classification Based on Fibrinogen Level and Fibrin Polymerization Associated With Postoperative Bleeding

Shingo Kawashima1, Yuji Suzuki2, Tsunehisa Sato3

  • 1Department of Anesthesiology and Intensive Care, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Insights

This study introduces a 4-group classification for cardiac surgery patients based on fibrinogen levels and fibrin polymerization, identifying higher bleeding risks in specific groups and improving transfusion management.

Area of Science:

  • Cardiovascular Surgery
  • Hemostasis and Thrombosis
  • Anesthesiology

Background:

  • Perioperative hemostasis is critical in cardiac surgery.
  • Fibrinogen and fibrin formation play vital roles in achieving hemostasis.
  • Effective management of bleeding complications is essential for patient outcomes.

Purpose of the Study:

  • To investigate the association between postoperative bleeding and a combined assessment of fibrinogen levels and fibrin polymerization.
  • To evaluate the utility of a novel 4-group classification (Fuji-san classification) in predicting bleeding risk.
  • To determine if this classification can optimize perioperative blood transfusion strategies.

Main Methods:

  • Retrospective analysis of 215 cardiac surgery patients.
  • Classification into 4 groups based on fibrinogen levels (<150 mg/dL) and fibrin polymerization (rotational thromboelastometry <6 mm at 10 minutes).
  • Assessment of chest tube drainage volume and intraoperative blood transfusions.

Main Results:

  • Groups with hypofibrinogenemia and/or low fibrin polymerization showed significantly increased risk of postoperative bleeding (>500 mL and >1000 mL).
  • Group III (hypofibrinogenemia and low fibrin polymerization) had the highest odds ratios for significant bleeding.
  • Stratifying fresh frozen plasma administration by the 4-group classification reduced intraoperative blood transfusions by 24.5%.

Conclusions:

  • The 4-group classification effectively correlates with postoperative bleeding after cardiac surgery.
  • This classification system can aid in identifying high-risk patients and guiding transfusion protocols.
  • Implementing this classification may enhance the quality of perioperative blood management in cardiac surgery.

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
771
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.7K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.1K